Cargando…
Optimal Patient Selection and Treatment Timing for Tolvaptan Therapy Following Cardiovascular Surgery
Autores principales: | Horie, Kotaro, Imamura, Teruhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992502/ https://www.ncbi.nlm.nih.gov/pubmed/36909136 http://dx.doi.org/10.1253/circrep.CR-23-0002 |
Ejemplares similares
-
Optimal Patient Selection and Treatment Timing for Tolvaptan Therapy Following Cardiovascular Surgery ― Reply ―
por: Matsuda, Yasuhiro, et al.
Publicado: (2023) -
How to Increase the Rate of Optimal Medical Therapy following Acute Myocardial Infarction
por: Imamura, Teruhiko
Publicado: (2020) -
Optimal device selection: Leadless versus conventional transvenous pacemakers
por: Kataoka, Naoya, et al.
Publicado: (2023) -
Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients
por: Bargagli, Matteo, et al.
Publicado: (2021) -
Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)